India MOH approves use of Exablate 4000 platform | Healthcare Asia Magazine
, India

India MOH approves use of Exablate 4000 platform

This will enable the treatment of Indian essential tremors, amongst others.

Insightec announced the market approval of its incisionless neurosurgery platform, the Exablate 4000, by the Central Drugs Standard Control Organization, a part of the Ministry of Health and Family Welfare of India.

"This approval adds to the growing recognition of the value of focused ultrasound for global healthcare systems," said Insightec CEO Maurice R. Ferré.

According to Jaslok Hospital Neurosurgery Director Paresh Doshi, "This technology offers appropriate patients immediate tremor control with a less invasive procedure that requires no incisions or anaesthesia with minimal complications. Global clinical studies have demonstrated the procedure as approved is safe and helps patients regain daily function."

The Exablate 4000 platform uses MR-guided precision ultrasound to ablate small targets deep within the brain without incisions.

Follow the links for more news on

Join Healthcare Asia Magazine community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!